Literature DB >> 25065930

The significance of histology: typical and atypical bronchial carcinoids.

Mariano García-Yuste1, José María Matilla2.   

Abstract

The aim of this study is to assess in bronchial carcinoid tumors, the prognostic factors in relation to the histology that would determine their most appropriate therapy. The histologic aggressiveness is a determining factor in tumor size and nodal involvement in these tumors. The knowledge of the histologic limits of typical and atypical carcinoid contributes to the recognition of a better valuation of the proportional significance that nodal involvement and histologic grade have in a tumor's prognosis.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Carcinoid tumors; Histology; Metastases; SSTR tumor receptors; Surgical procedure

Mesh:

Year:  2014        PMID: 25065930     DOI: 10.1016/j.thorsurg.2014.05.003

Source DB:  PubMed          Journal:  Thorac Surg Clin            Impact factor:   1.750


  4 in total

1.  The role of surgery in high grade neuroendocrine tumours of the lung.

Authors:  Stefan Welter; Clemens Aigner; Christian Roesel
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

2.  Prognostic significance of histopathological factors in survival and recurrence of atypical carcinoid tumours.

Authors:  Eva-María García-Fontán; Miguel-Ángel Cañizares-Carretero; Montserrat Blanco-Ramos; Jose-María Matilla-González; Rommel Carrasco-Rodríguez; Francisco Barreiro-Morandeira; Mariano García-Yuste
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-05-27

3.  Outcomes after surgical resection of pulmonary carcinoid tumors.

Authors:  Ikenna C Okereke; Angela M Taber; Rogers C Griffith; Thomas T Ng
Journal:  J Cardiothorac Surg       Date:  2016-03-02       Impact factor: 1.637

4.  Superior mediastinal typical carcinoid detected by 99mTc-MIBI SPECT/CT imaging: A case report.

Authors:  Chenghui Lu; Zenghua Wang; Guoqiang Wang; Xufu Wang; Xinfeng Liu
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.